Navigation Links
Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
Date:3/1/2012

ding GPCR structure determination. The company's lead program is a best‐in‐class S1P1 small molecule agonist candidate for autoimmune indications, including multiple sclerosis and inflammatory bowel disease, which will complete a Phase 1 clinical study in the first quarter of 2012. The S1P1 program is supported by the company's proprietary high resolution protein crystal structure of the S1P1 receptor. Receptos has established partnerships for its GPCR structure determination technology platform with Eli Lilly, Ono Pharmaceutical and Janssen Pharmaceuticals, Inc. For more information visit www.receptos.com.

Media and Investor Contacts:
Russo Partners
Ian Stone or David Schull (media)
(619) 308-6541 or (212) 845-4271
Ian.stone@russopartnersllc.com
David.schull@russopartnersllc.com

Cindy McGee (investors)
(619) 308-6538
Cindy.mcgee@russopartnersllc.com


'/>"/>
SOURCE Receptos Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Receptos Scientists Publish Determination of a High Resolution Sphingosine 1-Phosphate Receptor 1 Structure in Science
2. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
3. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
5. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
6. Regeneron Announces March 2012 Investor Conference Presentations
7. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
8. OncoSec to Present at 10th Annual BioPartnering North America
9. Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
10. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
11. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Pfenex Inc. ... the development of biosimilar therapeutics, today announced that it ... Francisco Marriott Marquis on March 2 nd at ... participate on a panel discussing the current state of ... of Biosimilars . For more information ...
(Date:2/27/2015)... 27, 2015  Steep Hill, the industry leader in ... intends to open a full service medical cannabis quality ... , bringing advanced scientific tools and methodology to the ... Hill is currently the only laboratory licensed by the ... contaminant testing in order to meet the recently adopted ...
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript,s ... judgment notwithstanding the verdict, a new trial, and remittitur. ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
Breaking Biology Technology:Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... June 3, 2011 Asmacure Ltee, a ... receptor agonists for the treatment of asthma and other ... appointed as chief executive officer.  With a solid foundation ... as it progresses its lead compound, a potential new ...
... better predict general patterns of evolution, a University of ... surprising things about gene mutations that might one day ... disease. UH evolutionary biologist Timothy Cooper and ... "Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial ...
... LIVONIA, Mich., June 2, 2011 Genentech and Novartis ... to Market Strategies International, a market research consultancy that ... more than 30 sales force, corporate equity and R&D ... and performance in this rapidly growing marketplace. ...
Cached Biology Technology:Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 2Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 3Work by UH evolutionary biologist may one day help with chronic diseases 2Genentech and Novartis Remain Image Leaders in Oncology and Hematology 2Genentech and Novartis Remain Image Leaders in Oncology and Hematology 3
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , ... it will showcase its EyeLock ID technology integrated in a ... Energy,s Oak Ridge National Laboratory (ORNL) at the ... identity authentication technology is being used to validate the driver ...
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric ... recent success of the Wocket™ smart wallet at CES 2015 in ... named as one of the "11 Hot Products at CES" in a ... CES So Far" by Newseveryday.com and "The top 10 gadgets from CES ...
(Date:1/22/2015)... , Europe,s most prestigious innovation prize ... present a video retrospective of the most exciting and innovative nominations  ... and Sophie Wilson   A different theme ... Starting on 22 January 2015 on   http://www.epo.org/european-inventor   ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... Palais des congrs de Montral, Montral, Qubec, Canada, 22-26 July ... -- The Society for the Study of Reproduction (SSR) ... 46th SSR Annual Meeting to be held in Montral, Qubec, ... page ( http://www.ssr.org/Meetings.shtml ) for details; information will be added ...
... known that animals flourish in regions where the climate ... set out to discover whether that same relationship held ... when dinosaurs roamed the Earth. "The assumption has ... ecosystems," said paleontologist and lead author Timothy S. Myers, ...
... Noah got it wrong? What if he paired a male ... and then discovered they were not the same and could ... Rescue and Conservation Project race to save frogs from a ... averts mating mix-ups., At the El Valle Amphibian Conservation Center, ...
Cached Biology News:Study finds Jurassic ecosystems were similar to modern: Animals flourish among lush plants 2Study finds Jurassic ecosystems were similar to modern: Animals flourish among lush plants 3Study finds Jurassic ecosystems were similar to modern: Animals flourish among lush plants 4
... NAP-10 Columns, 50. For rapid and efficient ... in less than 15 minutes by gravity ... distilled water containing 0.15% Kathon CG/ICP Biocide.Available ... 0.5 ml (NAP-5), 1 ml (NAP-10) ...
Human ROR1 Affinity Purified Polyclonal Ab...
Human Rad1 MAb (Clone 33)...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Biology Products: